Regeneron Pharmaceuticals (REGN)

Income Tax Expense

$837.30M

TTM · Period ending: · USD

REGN logo

REGN Income Tax Expense

Latest reported$837.30M
REGN TTM Income Tax ($0.00 → $837.30M)
High-resolution chart · PNG

REGN income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
837,300,000
733,500,000
725,800,000
567,100,000
416,200,000
484,900,000
367,300,000
314,900,000
265,500,000
184,200,000
245,700,000
385,300,000
476,400,000
473,000,000
520,400,000
667,200,000
657,500,000
1,200,300,000
1,250,500,000
1,051,500,000
1,023,300,000
391,000,000
297,200,000
319,600,000
262,300,000
272,300,000
313,300,000
71,300,000
13,606,000
86,668,000
109,086,000
634,534,000
770,616,000
804,060,000
880,000,000
587,164,000
510,953,000
468,885,000
449,942,000
433,825,000
515,639,000
552,954,000
589,041,000
627,857,000
541,324,000
518,355,000
427,673,000
417,909,000
405,929,000
355,861,000
288,998,000
-148,197,000
-233,092,000
-293,909,000
-336,866,000
-1,633,000
-554,000
-916,000
-1,132,000
329,000
-1,139,000
-1,460,000
-1,026,000
-5,994,000
-5,088,000
-3,904,000
-7,622,000
-4,228,000
-1,149,000
-5,683,000
-13,780,000
-12,988,000
-24,736,000
-30,873,000
-29,751,000
-32,330,000
-23,661,000
-13,663,000
-4,471,000
244,165,000
241,684,000
229,010,000
178,846,000
-67,925,000
-65,264,000
-51,116,000
-84,281,000
-82,261,000
-82,029,000
-82,127,000
3,008,000
963,000
-1,186,000
-3,970,000
-7,011,000
-10,237,000
-15,025,000
-19,489,000
-17,594,000
-6,372,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.